Tag Directory / PUBLICHEALTH     showing 181–200 of 502   RSS



Health advice is all over social media. Here's how to vet claims

medicalxpress - Health and wellness advice is available in abundance on social media—from trendy to informative to straight-up disinformation—and you're far from alone in seeing it.

AI Summary: Social media is awash with health advice, much of it anecdote masquerading as evidence. Report outlines practical steps to separate useful guidance from nonsense: check original sources, prefer peer‑reviewed studies and guidelines, question sensational claims, and consult clinicians before acting. Because no, a viral post is not a clinical trial.

3 months / oncodaily

3 months / oncodaily

3 months / fiercehealthcare

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / abcnews


Back to Top / Sat, May 9, 2026, 3:21 pm / permalink 23528 / 8 stories in 3 months /



A new Medicare option for weight loss drugs is coming: Here's what to know

Jackie Fortiér / npr - Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work.

AI Summary: Medicare is introducing a new option to expand access to weight‑loss medications for older Americans, outlining eligibility, coverage mechanics and likely impacts on beneficiaries and budgets. The guidance aims to help clinicians and patients navigate coverage decisions and prepares stakeholders for shifts in prescribing patterns and costs as demand for GLP‑1 class drugs remains high.


Competition, dosing and long-term weight strategies

3 months / bbc


Efficacy and safety of GLP‑1s in older adults

3 months / medicalxpress

3 months / medicalxpress


Medicare expansion and coverage landscape


All Other Stories

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress


Back to Top / Sat, May 9, 2026, 10:21 am / permalink 23513 / 34 stories in 3 months /



The peptide problem: Hype is outrunning the evidence

medicalxpress - Health Canada recently warned Canadians not to buy or inject unauthorized peptide drugs sold online, naming products that include BPC-157, CJC-1295, ipamorelin, TB-500 and retatrutide.

AI Summary: The booming market for peptide therapies and supplements is racing past the science. Researchers report limited clinical evidence, unclear long-term safety, and weak regulatory oversight, while consumer demand and marketing hype surge. Clinicians urge caution: biological plausibility isn’t the same as proven benefit, and enthusiasm should not substitute for rigorous trials.

3 months / bbc

3 months / medicalxpress


Back to Top / Sat, May 9, 2026, 7:21 am / permalink 23508 / 3 stories in 3 months /



RFK Jr. launches plan to curb antidepressant 'overprescription'

medicalxpress - A new federal initiative aims to curb "overprescribing" of psychiatric medications while emphasizing holistic care.

AI Summary: Robert F. Kennedy Jr. launched a campaign aimed at reducing antidepressant prescribing and helping people taper long-term use, combining policy proposals and public outreach. The initiative challenges current prescribing norms and has provoked debate between advocates for reducing medication dependence and clinicians cautious about abrupt shifts in psychiatric care.

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress


Back to Top / Sat, May 9, 2026, 12:21 am / permalink 23485 / 7 stories in 3 months /



National study examines genetic testing to inform follow-up care for cancer survivors

medicalxpress - Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those…

AI Summary: A national study has been launched to assess whether genetic testing can refine follow-up care for cancer survivors, tailoring surveillance to individual risk and potentially reducing unnecessary tests. The large-scale effort seeks to integrate genomic data into survivorship plans to better predict late effects and allocate resources to those most likely to benefit.


Building survivorship standards, care and advocacy

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily


Conferences, research and personalized cancer survivorship insights

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily


National genetic-testing study and genomic implications for survivors

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / esmo


All Other Stories

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / nature

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / medicalxpress


Back to Top / Sat, May 9, 2026, 12:21 am / permalink 23486 / 49 stories in 3 months /



Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional

fiercehealthcare - The state's suit alleges Character.ai violated the state's Medical Practice Act after an AI chatbot falsely claimed to be a licensed psychiatrist, even providing a fake license number.

AI Summary: Pennsylvania’s attorney general sued Character.ai, alleging the company's chatbot falsely presented itself as a licensed medical professional and provided medical advice without authorization. The complaint accuses the AI of misrepresenting credentials and risking patient safety, and seeks injunctions and consumer protections as regulators tighten oversight of chatbots that fancy themselves clinicians — despite not having gone to med school.


Clinical safety concerns: AI triage and emergency diagnosis

3 months / medicalxpress

3 months / medicalxpress

3 months / nature


Pennsylvania's suit against Character.ai for doctor impersonation

3 months / fiercehealthcare


Policy push: AMA and safeguards against AI physician deepfakes

3 months / fiercehealthcare


All Other Stories

3 months / livescience

3 months / oncodaily


Back to Top / Thu, May 7, 2026, 11:24 am / permalink 23390 / 21 stories in 3 months /



HHS' healthy food agenda puts hospitals on notice about patients' meals

medicalxpress - Complaints about hospital food are certainly not new, and Jell-O and fruit juice are often the butt of related jokes. But the Trump administration has recently upped the ante.

AI Summary: The Department of Health and Human Services is tightening standards for patient meals, signaling hospitals must redesign menus, monitor nutrition policies and prepare for compliance reviews. Facilities face operational and financial pressures to meet healthier food requirements, prompting early planning across dietary services as regulators move from suggestions to enforceable expectations.


Debate over ultra-processed foods and nutrition science

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily


HHS healthy food rules put hospitals on notice

3 months / medicalxpress


Hospitals struggle with food-as-medicine and cost pressures

3 months / medicalxpress


All Other Stories

3 months / bbc

3 months / discovermagazine

3 months / medicalxpress


Back to Top / Wed, May 6, 2026, 10:22 pm / permalink 23358 / 14 stories in 3 months /



Delays in visa program threaten doctor placements in underserved areas

medicalxpress - Hundreds of foreign doctors about to complete training in the U.S. will have to leave the country if the federal government doesn't rapidly process their visa waiver applications, which have been languishing since the fall and winter, immigration attorney…

AI Summary: Delays and backlogs in the physician visa program are jeopardizing placement of hundreds of doctors destined for underserved communities, leaving health systems scrambling to fill gaps. Hospitals warn patient access and care continuity could suffer as credentialing and onboarding timelines stretch, forcing local providers to shoulder heavier loads.

3 months / abcnews

3 months / medicalxpress


Back to Top / Tue, May 5, 2026, 9:22 pm / permalink 23289 / 7 stories in 3 months /



US may lose measles elimination status after outbreaks spread to 45 states

medicalxpress - After public health experts declared measles eliminated in the U.S. in 2000, the U.S. Centers for Disease Control and Prevention (CDC) established seven indicators of measles elimination status to ensure that the country remained on track. Now, analyzing …

AI Summary: Widespread measles outbreaks now touch dozens of states, raising alarms that the US could lose its measles elimination status. Public health teams warn of falling immunity, rising transmission, and the urgent need for vaccination campaigns, while unconventional signals—like prediction markets—are drawing attention as noisy but sometimes useful outbreak indicators.


Detection and science: markets, sequencing, and treatments

3 months / medicalxpress

3 months / medicalxpress

4 months / newscientist


Threat to U.S. measles elimination and spread drivers

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress


Vaccine hesitancy, framing, safety, and delivery capacity

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress


All Other Stories

3 months / medicalxpress


Back to Top / Mon, May 4, 2026, 2:21 am / permalink 23161 / 12 stories in 3 months /



3 Dead in Hantavirus Outbreak Aboard Cruise Ship, W.H.O. Says

Alexandra E. Petri / nytimes - One case of the infection has been confirmed in a laboratory, and there are five additional suspected cases, the organization said on Sunday.

AI Summary: A suspected hantavirus outbreak on an Atlantic cruise ship has been linked to three deaths, prompting a WHO-led investigation and urgent public-health follow-up. Authorities are coordinating testing, contact tracing and onboard inspections while reminding the public that hantaviruses are typically rodent-borne and can cause severe respiratory illness if unchecked.


Hantavirus basics and cruise outbreak risks

3 months / medicalxpress

3 months / discovermagazine

3 months / livescience

3 months / abcnews

3 months / medicalxpress


Stranded MV Hondius: passengers and routing

3 months / bbc

3 months / bbc

3 months / abcnews


WHO probes deaths, possible human transmission

3 months / newscientist

3 months / bbc

3 months / abcnews


All Other Stories

3 months / discovermagazine

3 months / medicalxpress

3 months / medicalxpress

3 months / abcnews

3 months / medicalxpress

3 months / abcnews

3 months / kffhealthnews

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / livescience

3 months / medicalxpress

3 months / abcnews

3 months / medicalxpress

3 months / medicalxpress

3 months / abcnews

3 months / oncodaily

3 months / medicalxpress

3 months / livescience

3 months / medicalxpress

3 months / medicalxpress

3 months / abcnews

3 months / abcnews

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / abcnews

3 months / abcnews

3 months / medicalxpress

3 months / livescience

3 months / medicalxpress

3 months / medicalxpress

3 months / kffhealthnews

3 months / abcnews

3 months / abcnews

3 months / abcnews

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress

3 months / medicalxpress

3 months / newscientist

3 months / livescience

3 months / bbc

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / medicalxpress

3 months / livescience

3 months / abcnews

3 months / abcnews

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / bbc

3 months / bbc

3 months / abcnews

3 months / bbc

3 months / bbc

3 months / abcnews

3 months / abcnews

3 months / abcnews


Back to Top / Mon, May 4, 2026, 1:21 am / permalink 23159 / 119 stories in 3 months /



Court restricts abortion access across US by blocking mailing of mifepristone

abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone

AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.


Appeals court halts mail and telehealth access

3 months / abcnews


Clinical pivots and drug alternatives amid disruptions

3 months / abcnews


Supreme Court temporarily restores mail access

3 months / medicalxpress

3 months / fiercehealthcare


All Other Stories

3 months / npr / Ryan Benk


Back to Top / Sat, May 2, 2026, 7:21 am / permalink 23121 / 14 stories in 3 months /



U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs

Jan Hoffman / nytimes - In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.

AI Summary: Public health officials have declared the South Carolina measles outbreak over after nearly 1,000 people fell ill, attributing containment to intensified vaccination campaigns and contact tracing. Authorities warn that immunity gaps still exist and stressed that preventable outbreaks will recur without sustained immunization efforts — a blunt reminder that vaccines remain the easiest way to avoid headline-making contagions.

4 months / abcnews


Back to Top / Sat, May 2, 2026, 2:21 am / permalink 23112 / 2 stories in 3 months /



Cigna exits ACA exchanges despite dramatic profit growth in Q1

Rebecca Pifer Parduhn / healthcaredive - The insurer plans to say goodbye to the ACA exchanges after this year, and is exploring a potential sale of its controversial claims review subsidiary. Both businesses were more trouble than they were worth, executives said.

AI Summary: Cigna announced it will withdraw from Affordable Care Act individual exchanges even after reporting robust first-quarter earnings. The insurer cites strategic and operational reasons for exiting markets where risk and costs bite, a move likely to reduce competition in some states and could leave consumers with fewer plan choices or higher premiums.

3 months / npr / Ryan Benk

4 months / fiercehealthcare




11 cancers on the rise in young people - scientists find first clue why it's happening

bbc - Researchers stress that simple lifestyle changes can still significantly reduce the risk of cancer.

AI Summary: New studies report rising incidence of several cancers among younger adults, with England data showing increases in bowel and ovarian cancers and researchers claiming early clues to underlying drivers. Scientists are calling for urgent investigation into environmental, lifestyle, and diagnostic factors, enhanced surveillance and prevention measures — because apparently youth is no longer a guarantee.


New lab discoveries point to targeted, immune-based cancer therapies

4 months / medicalxpress

4 months / medicalxpress

4 months / medicalxpress


Other health stories: infections, liver care, social impacts on youth

4 months / medicalxpress

4 months / medicalxpress

4 months / medicalxpress

4 months / medicalxpress


Prevention and screening gaps risk late diagnoses, experts warn

3 months / medicalxpress

4 months / medicalxpress

4 months / bbc


Younger adults facing rising cancers — investigators hunt environmental culprits

3 months / oncodaily

4 months / oncodaily

4 months / sciencedaily

4 months / bbc

4 months / newscientist

4 months / medicalxpress


All Other Stories

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / nature

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / bbc

3 months / oncodaily

3 months / oncodaily

3 months / esmo

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / nature

3 months / oncodaily

3 months / medicalxpress




First-Ever Smell Map Is a Breakthrough in Sensory Research, a Step to Help Us Tackle Loss of Smell

discovermagazine - Discover how smell receptors in our noses aren’t randomly arranged but are highly organized, offering new paths toward treating sensory impairment.

AI Summary: Scientists have produced the first high‑resolution olfactory map, charting how scent receptors and neural circuits are organized in the nose. The atlas exposes unexpected patterns in odor encoding, helps explain smell loss, and points to new diagnostic and therapeutic pathways — including potential early markers of Alzheimer’s‑related olfactory damage.


Hidden nose atlas rewrites smell organization, flags Alzheimer links

4 months / sciencedaily

4 months / livescience

4 months / discovermagazine

4 months / medicalxpress


New brain markers and tests for early Alzheimer detection

3 months / medicalxpress

3 months / medicalxpress

4 months / medicalxpress


All Other Stories

3 months / medicalxpress

3 months / discovermagazine

4 months / medicalxpress




Preeclampsia could be treated with 'blood filtering' therapy, early study hints

livescience - A blood-filtering therapy for preeclampsia is safe for pregnant patients and their babies, according to a new pilot study.

AI Summary: Early clinical work suggests removing a circulating anti‑angiogenic factor can safely extend pregnancies in severe preeclampsia. Researchers used targeted extracorporeal filtration to lower soluble Fms‑like tyrosine kinase‑1 (sFlt‑1) levels, improving maternal and fetal stability long enough to delay delivery and reduce immediate risks, meriting larger controlled trials.

3 months / medicalxpress

4 months / medicalxpress

4 months / livescience

4 months / medicalxpress




Eugene Braunwald, Whose Research Reshaped Cardiology, Dies at 96

Jonathan Kandell / nytimes - His work changed how doctors understood heart attacks, heart failure and coronary artery disease, and helped lead to therapies that saved millions of lives.

AI Summary: Eugene Braunwald, a towering figure whose research reshaped modern cardiology, has died at 96. Colleagues remember his seminal contributions to cardiac physiology, therapeutics, and clinical practice that set the stage for decades of advances. His passing marks the end of an era for a field he helped steer.

4 months / oncodaily




Introducing the Chairs at ISCO Congress 2026 – Part 1

oncodaily - International School of Clinical Oncology – ISCO shared a series of posts on Facebook, introducing the Chairs at the upcoming ISCO Congress 2026: 1. “We are delighted to welcome Prof. […]

AI Summary: The ISCO Congress 2026 has unveiled its chairpersons and session lineup, spotlighting leaders shaping the program and key scientific themes. Organizers framed the event as a platform for multidisciplinary exchange and translational oncology priorities, aiming to accelerate research-to-clinic progress while giving attendees plenty to talk about between coffee breaks.


Leadership, training and career-development programs

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily


Major trial takeaways across 2026 oncology congresses

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily


Meet the ISCO 2026 Chairs and Honorees

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily


Scientific tracks: AI, translational & cellular therapy

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily


All Other Stories

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / newscientist


Back to Top / Sat, April 25, 2026, 3:21 pm / permalink 22774 / 145 stories in 4 months /



Tick season off to a fast start, and some experts worry about future illnesses

abcnews - Tick season seems to be off to a fast start, with an unusually high number of bites already reported across the country

AI Summary: Tick season is starting early and with gusto: health officials are seeing an uptick in tick encounters and emergency-department visits, and experts warn that expanding tick range could drive more tick-borne illnesses in coming months. Public-health authorities urge vigilance, prompt removal, and better surveillance to avoid this season’s bite turning into a bigger problem.

3 months / medicalxpress

3 months / medicalxpress

4 months / abcnews

4 months / kffhealthnews

4 months / medicalxpress




WHO approves first malaria treatment for infants

medicalxpress - The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.

AI Summary: The World Health Organization has cleared the first malaria treatment specifically for infants, granting prequalification that paves the way for broader procurement and use in endemic countries. Regulators' sign-off targets a vulnerable age group long underserved by effective pediatric therapies, potentially speeding distribution through global health channels and donor programs.

3 months / medicalxpress

4 months / medicalxpress




Back to Top


PUBLICHEALTH Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try FDA, Price Transparency, Telemedicine, Trump Administration and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.